Ángel Cabrera/president.gatech.edu;David Ku/LinkedIn
Jun 26, 2026, 13:25
Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
Ángel Cabrera, President at Georgia Institute of Technology, shared a post on LinkedIn:
“It affects 1/3 of the human population and can be severe enough to lead to hospitalization.
Yet its causes remain a mystery, it’s rarely discussed in public, often goes undiagnosed, and it remains a consistently underfunded and understudied area of science.
My colleague David Ku and his team are changing that by studying how clotting disorders contribute to heavy menstrual bleeding.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
-
Jun 26, 2026, 10:11Kayla Kilani: First-Ever CT Perfusion Scan Performed Inside a Mobile Stroke Unit